MAY 03, 2016 6:59 PM PDT

Aerobic respiration helps gut pathogens fluorish

WRITTEN BY: Kerry Evans
Antibiotics cure infections, right? Well, not always. A new study published in Cell Host & Microbe details how antibiotics can select for the growth of pathogenic bacteria in the gut.

Researchers from UC Davis found that antibiotics create a niche within the gut that helps pathogens like Salmonella flourish. Essentially, antibiotics wipe out the “good” bacteria living in the gut. These bacteria help us break down complex carbohydrates in dietary fiber, producing butyrate. Butyrate is taken up by intestinal epithelial cells and used to convert oxygen to carbon dioxide. Without the butyrate-producing bacteria, oxygen escapes into the intestinal lumen, creating an ideal environment for pathogenic Salmonella to grow.

According to study author Andreas Baumler, “Unlike Clostridia and other beneficial microbes in the gut, which grow anaerobically, or in the complete absence of oxygen, Salmonella flourished in the newly created oxygen-rich microenvironment after antibiotic treatment … in essence, antibiotics enabled pathogens in the gut to breathe”.
 
Antibiotics help Salmonella compete with gut flora.
The group showed that Salmonella coupled aerobic and nitrate respiration to grow in the guts of streptomycin-treated mice. They constructed a mutant that lacked the ability to use oxygen and nitrate and found that its fitness was severely compromised - after 4 days of infection, nearly 2,000-fold more wild type Salmonella were recovered compared to the mutant. Interestingly, similar numbers of the wild type and mutant cells were recovered from mice that had not been treated with streptomycin. This suggests that the ability to use oxygen and nitrate for respiration contributed to the so-called “post-antibiotic pathogen expansion”.

Interestingly, a decrease in the number of butyrate-producing bacteria has been linked to inflammatory bowel disease. Butyrate was found to decrease the production of proinflammatory cytokines in the gut by inhibiting the activity of NF-κB. Similarly, one study found that butyrate increased the number of T regulatory cells in the gut, possibly alleviating inflammation. According to study author Hiroshi Ohno, “butyrate is natural and safe as a therapy and in addition to that it is cheap, which could reduce costs for both patients and society”.
 

Sources: UC Davis, Cell Host & Microbe, Gut, Science 2.0
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
NOV 27, 2019
Genetics & Genomics
NOV 27, 2019
Humans Are Continuing to Evolve, Along With Immune-Related Diseases
Humans have evolved in some ways to be less susceptible to pathogens, but those benefits can also carry risks of other diseases....
JAN 11, 2020
Microbiology
JAN 11, 2020
Twins Still Have Microbial Strains in Common After Living Apart for Years
Twins can offer researchers an opportunity to study health and biology in people with the same genes, raised in the same environment....
JAN 27, 2020
Microbiology
JAN 27, 2020
Microbes in Household Dust May Be Spreading Antibiotic Resistance
Bacteria live in household dust, and sometimes a few of those microbes are pathogenic or carry genes that confer resistance to antibiotics....
JAN 30, 2020
Microbiology
JAN 30, 2020
25% of Antibiotic-Resistant Bacteria Can Spread Resistance Directly to Other Microbes
This research also suggests that antibiotics do not increase the rate at which bacteria acquire drug resistance genes....
FEB 09, 2020
Microbiology
FEB 09, 2020
Investigating the Links Between Viruses and Cancer
The Pan-Cancer Analysis of Whole Genomes (PCAWG) has brought over 1,300 scientists together to gain new insights into the genetics of cancer....
FEB 24, 2020
Microbiology
FEB 24, 2020
The World Tries to Stop the Global Spread of COVID-19
There's been a rise in harmful stereotyping and discrimination against certain populations because of coronavirus....
Loading Comments...